MedPath

Effect of canagliflozin for postprandial glucose control

Not Applicable
Conditions
Type 2 diabetes
Registration Number
JPRN-UMIN000030596
Lead Sponsor
St Marianna University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
15
Inclusion Criteria

Not provided

Exclusion Criteria

1)Type 1 diabetes,2)Patients whose blood glucose level is less than 100 mg /dL on under insulin or sulfonylurea treatment, 3)Patients with postvoid residual urine of benign prostatic hyperplasia and neurogenic bladder,4)eGFR<30mL/min/1.73m2,5)Women who were pregnant, possibly pregnant, or were breast-feeding,6)Genital infection or urinary tract infection,7)Being treated diuretics,8)Insulin-dependent type 2 diabetes,9)Other patients who were considered to be ineligible for the study by the attending doctor

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath